Lv3
300 积分 2022-09-20 加入
Therapeutic horizons in metabolic dysfunction–associated steatohepatitis
15天前
已完结
Assessing Longitudinal Risk Factors for Worsening Health Outcomes in Pediatric Metabolic Dysfunction-associated
16天前
已关闭
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2个月前
已完结
Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights
2个月前
已关闭
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
4个月前
已完结
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study
6个月前
已完结
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
7个月前
已完结
Pathological Evolution and Internal Medicine Management of Nonalcoholic Fatty Liver Disease (NAFLD) in the Era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
8个月前
已完结
皖公网安备34019202002308
